Guiyang Xintian Pharmaceutical Co., Ltd.

29
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002QB5
CNY
10.53
-0.11 (-1.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
842.00
940.00
1,074.00
956.00
739.00
761.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
842.00
940.00
1,074.00
956.00
739.00
761.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
18.00
12.00
11.00
18.00
7.00
6.00
General and Administration Expenses
505.00
578.00
671.00
602.00
467.00
488.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
783.00
842.00
947.00
830.00
653.00
677.00
Operating Profit (PBDIT) excl Other Income
59.00
98.00
126.00
125.00
86.00
84.00
Other Income
20.00
5.00
7.00
7.00
4.00
6.00
Operating Profit (PBDIT)
118.00
130.00
160.00
160.00
112.00
107.00
Interest
18.00
12.00
11.00
18.00
7.00
6.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
38.00
24.00
26.00
25.00
21.00
17.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
60.00
92.00
121.00
116.00
83.00
83.00
Provision for Tax
8.00
11.00
9.00
16.00
9.00
12.00
Profit After Tax
52.00
80.00
111.00
100.00
74.00
71.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.24
0.33
0.46
0.41
0.31
0.32
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -10.44% vs -12.43% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -39.44% vs -22.51% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 45.83% vs 8.67% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is -35.30% vs -27.48% in Dec 2023

Compare Profit and Loss Results of Guiyang Xintian Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
842.00
0
842.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
842.00
0
842.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
0.00
0
0.00
0%
Operating Expenses
18.00
0
18.00
0%
General and Administration Expenses
505.00
0
505.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
783.00
0
783.00
0%
Operating Profit (PBDIT) excl Other Income
59.00
0.00
59.00
0%
Other Income
20.00
0
20.00
0%
Operating Profit (PBDIT)
118.00
0
118.00
0%
Interest
18.00
0
18.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
38.00
0
38.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
60.00
0
60.00
0%
Provision for Tax
8.00
0
8.00
0%
Profit After Tax
52.00
0
52.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.2375
0
0.24
0%
Profit And Loss - Net Sales
Net Sales 842.71 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -10.44% vs -12.43% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.56 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -39.44% vs -22.51% in Dec 2023

Profit And Loss - Interest
Interest 18.86 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 45.83% vs 8.67% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 52.32 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -35.30% vs -27.48% in Dec 2023